Introduction

Methods
Using a combination of neutrophil cell counts and fluid phase inflammatory mediators we defined an inflammatory phenotype that was shown to be reproducible and more robust than sputum neutrophils alone. The approach to use a combination of inflammatory markers could be helpful in studies that try to relate persistent airway inflammation to exacerbation rates, to long term changes in disease severity and prognosis, especially in the field of COPD research and for ongoing large cohort trials.
Conclusion
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The top four most reproducible sputum inflammatory markers (A1AT, IL6, MMP7, HSA, see table below)) and the percentage of sputum neutrophils were combined to define an inflammatory phenotype (IP) independently for both visits.
Results
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112.5 ± 14.1 60.5 ± 6.8*** FVC [L] 5.1 ± 1.0 4.2 ± 0.9** FEV 1 /FVC [%] 75.4 ± 5.0 48.7 ± 7.4*** pO2 [mm Hg] 82.9 ± 9.7 73.3 ± 5.3***
The IP showed a better reproducibility (r=0.70; p<0.001) between visits as compared to the percentage of sputum neutrophils and correlated significantly with BAL (r=0.55, p<0.001) but not with serum calprotectin levels (r=0.25). Correlations with other serum markers were weak, being best for WBC count (r=0.5, p=0.002). No relationship to biopsy neutrophils was found. The list of markers analysed in induced sputum is presented in the 2 following tables. These show the differences between groups for the first visit. The levels of a1-AT, HSA, and MMP3 were lower in smokers with COPD.
